Published in Biomark Med on December 01, 2011
HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome. Semin Immunopathol (2015) 0.97
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis (2008) 5.94
Immune restoration disease after antiretroviral therapy. AIDS (2004) 4.54
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet (2010) 3.90
Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity. Clin Infect Dis (2010) 3.71
Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology (2011) 3.45
The TREAT Asia HIV Observational Database: baseline and retrospective data. J Acquir Immune Defic Syndr (2005) 3.18
Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell (2010) 2.91
Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis (2009) 2.89
Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis (2010) 2.86
HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia. Lancet (2005) 2.83
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr (2014) 2.79
Sustainability science: an integrated approach for health-programme planning. Lancet (2008) 2.73
An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Diabetes Care (2005) 2.51
Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol (2010) 2.50
High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother (2004) 2.41
Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet (2010) 2.26
Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B. Am J Gastroenterol (2007) 2.25
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy. J Infect Dis (2009) 2.24
Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India. J Gastroenterol Hepatol (2008) 2.09
HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis (2011) 2.08
Vitamin D levels in Indian children with intrathoracic tuberculosis. Indian J Med Res (2014) 2.07
Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia. J Virol (2008) 2.07
Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger? PLoS Negl Trop Dis (2010) 2.03
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis (2012) 2.01
Nickel-Containing Carbon Monoxide Dehydrogenase/Acetyl-CoA Synthase(,). Chem Rev (1996) 2.00
Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr (2006) 1.97
Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis (2011) 1.77
Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. Int J Epidemiol (2010) 1.76
Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc (2002) 1.76
Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med (2009) 1.76
Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis (2011) 1.74
Emerging HIV epidemics in Muslim countries: assessment of different cultural responses to harm reduction and implications for HIV control. Curr HIV/AIDS Rep (2007) 1.70
Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B. J Acquir Immune Defic Syndr (2010) 1.69
Retracted Insect vectors of Leishmania: distribution, physiology and their control. J Vector Borne Dis (2008) 1.67
Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy (2007) 1.65
Chemotherapy of leishmaniasis: past, present and future. Curr Med Chem (2007) 1.62
Urine as an adjunct specimen for the diagnosis of active pulmonary tuberculosis. Int J Infect Dis (2008) 1.61
Current HIV/AIDS/STI epidemic: intervention programs in Cambodia, 1993-2003. AIDS Educ Prev (2004) 1.53
Versatile photosensitizers for photodynamic therapy at infrared excitation. J Am Chem Soc (2007) 1.53
Bacterial glycoproteins: functions, biosynthesis and applications. Proteomics (2003) 1.52
TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS (2011) 1.51
Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Organ (2013) 1.50
Malaysia and harm reduction: the challenges and responses. Int J Drug Policy (2007) 1.49
Elevation of radiolabelled thymidine uptake in RIF-1 fibrosarcoma and HT29 colon adenocarcinoma cells after treatment with thymidylate synthase inhibitors. Eur J Nucl Med Mol Imaging (2006) 1.47
Food handlers' beliefs and self-reported practices. Int J Environ Health Res (2002) 1.47
Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome. AIDS (2013) 1.46
Assessment of the N-PCR assay in diagnosis of pleural tuberculosis: detection of M. tuberculosis in pleural fluid and sputum collected in tandem. PLoS One (2010) 1.46
Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey. Epilepsia (2005) 1.45
Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ (2013) 1.44
Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J (2013) 1.43
CD4+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4+ T cells. J Infect Dis (2011) 1.40
A clinical investigation into the microbiological status of 'locally infected' leg ulcers. Int Wound J (2009) 1.40
Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis. Eur Neurol (2009) 1.40
A phosphate transporter from the root endophytic fungus Piriformospora indica plays a role in phosphate transport to the host plant. J Biol Chem (2010) 1.38
Hepatitis B and C virus co-infections in human immunodeficiency virus positive North Indian patients. World J Gastroenterol (2006) 1.33
Implementing methadone maintenance treatment in prisons in Malaysia. Bull World Health Organ (2013) 1.33
Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India. BMC Infect Dis (2010) 1.32
Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis (2012) 1.30
Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network. J Infect Dis (2011) 1.29
Hepatitis B in health care workers: Indian scenario. J Lab Physicians (2009) 1.29
An overview on 5alpha-reductase inhibitors. Steroids (2009) 1.29
HIV-related risk behaviors in Cambodia and effects of mobility. J Acquir Immune Defic Syndr (2006) 1.28
Anti-inflammatory treatments for chronic diseases: a review. Inflamm Allergy Drug Targets (2013) 1.28
Epigenetics and its role in male infertility. J Assist Reprod Genet (2012) 1.27
Genome sequence of a novel HIV-1 circulating recombinant form 54_01B from Malaysia. J Virol (2012) 1.25
SPIRAL2 determines plant microtubule organization by modulating microtubule severing. Curr Biol (2013) 1.25
Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett (2012) 1.24
Persistent immune activation in chronic HIV infection: do any interventions work? AIDS (2013) 1.24
Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients. J Acquir Immune Defic Syndr (2011) 1.24
Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr (2011) 1.24
Immunobiology of leishmaniasis. Indian J Exp Biol (2009) 1.23
Genome sequences of a novel HIV-1 CRF53_01B identified in Malaysia. J Virol (2012) 1.23
Synthesis and anti-inflammatory activity of novel biscoumarin-chalcone hybrids. Bioorg Med Chem Lett (2011) 1.22
Immune restoration diseases reflect diverse immunopathological mechanisms. Clin Microbiol Rev (2009) 1.21
Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease. J Med Virol (2006) 1.20
Whole-genome analysis of Oryza sativa reveals similar architecture of two-component signaling machinery with Arabidopsis. Plant Physiol (2006) 1.20
Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani. Protein Expr Purif (2005) 1.19
Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis (2010) 1.19
Molecular signatures of T-cell inhibition in HIV-1 infection. Retrovirology (2013) 1.19
Finding a cure for HIV: will it ever be achievable? J Int AIDS Soc (2011) 1.18
Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome. J Infect Dis (2013) 1.18
Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J Antimicrob Chemother (2010) 1.16
Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD). J Acquir Immune Defic Syndr (2009) 1.16
Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend (2013) 1.15
A randomised controlled 8-week crossover clinical evaluation of the 3M Coban 2 Layer Compression System versus Profore to evaluate the product performance in patients with venous leg ulcers. Int Wound J (2008) 1.15
Emergence and continued circulation of dengue-2 (genotype IV) virus strains in northern India. J Med Virol (2004) 1.15
Prospective multicentre randomised controlled trial of early enteral nutrition for patients undergoing major upper gastrointestinal surgical resection. Clin Nutr (2011) 1.14
Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. J Antimicrob Chemother (2010) 1.14
Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. Indian J Med Res (2010) 1.13
HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manage (2010) 1.12
Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis (2009) 1.12